Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Kimberly M BurcherChance H BloomerElena GavrilaJohn M KaladaMark J ChangRediet R GebeyehuAlexander H SongLara M KhouryThomas W LycanRebecca KinneyRalph D'AgostinoPaul M BunchKirtikar ShuklaPierre TriozziCristina M FurduiWei ZhangMercedes PorosnicuPublished in: Therapeutic advances in medical oncology (2024)
This study is registered on ClinicalTrials.gov: NCT04375384.